Supplemental material
Future Cardiology
Volume 18, 2022 - Issue 5
Meta Analysis
Real-world Evidence Comparing Oral Anticoagulants in non-valvular Atrial Fibrillation: A Systematic Review and Network meta-analysis
Steven Deitelzweig1 Ochsner Health System Department of Hospital MedicineNew OrleansLA70121USACorrespondence[email protected]
https://orcid.org/0000-0002-5639-6484
https://orcid.org/0000-0002-5639-6484, Evelien Bergrath2 Regeneron Pharmaceuticals Inc. Health Economics and Outcomes Research TarrytownNY10591USAhttps://orcid.org/0000-0002-4351-4170
https://orcid.org/0000-0002-4351-4170, Manuela di Fusco3 Pfizer Inc. Health Economics and Outcomes ResearchNew YorkNY10017USAhttps://orcid.org/0000-0003-0079-7331
https://orcid.org/0000-0003-0079-7331, , , Joseph C Cappelleri3 Pfizer Inc. Health Economics and Outcomes ResearchNew YorkNY10017USAhttps://orcid.org/0000-0001-9586-0748
https://orcid.org/0000-0001-9586-0748, Cristina Russ3 Pfizer Inc. Health Economics and Outcomes ResearchNew YorkNY10017USAhttps://orcid.org/0000-0001-7248-9712
https://orcid.org/0000-0001-7248-9712, Marissa Betts5 Evidera Evidence Synthesis Modeling & Communication WalthamMA02451USAhttps://orcid.org/0000-0002-0557-3946
https://orcid.org/0000-0002-0557-3946, Allie Cichewicz5 Evidera Evidence Synthesis Modeling & Communication WalthamMA02451USAhttps://orcid.org/0000-0002-8528-9901
https://orcid.org/0000-0002-8528-9901, , & Kyle Fahrbach5 Evidera Evidence Synthesis Modeling & Communication WalthamMA02451USAhttps://orcid.org/0000-0003-2879-2663
https://orcid.org/0000-0003-2879-2663 show all